Home » Topics » Regulatory » Patents

Patents
RSS

Boehringer Ingelheim Pharma GmbH discloses free fatty acid receptor 1 agonists

March 27, 2017

Ocean University of China describes new anti-HSV-1 compounds

March 24, 2017

Bristol-Myers Squibb synthesizes novel myeloperoxidase and/or eosinophil peroxidase inhibitors

March 24, 2017

Janssen Pharmaceutica synthesizes novel analgesic compounds

March 24, 2017

Santen Pharmaceutical patents glucocorticoid receptor agonists

March 24, 2017

Janssen identifies novel cannabinoid receptor 1 inverse agonists

March 24, 2017

Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors

March 23, 2017

Shenzhen Qingyaqirui Bio-Tech identifies new conjugates of memantine and arctigenin

March 23, 2017

Bayer Pharma discovers coagulation factor XIa and kallikrein inhibitors

March 23, 2017

Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors

March 23, 2017

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...